arginine has been researched along with Cardiac Failure in 163 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (3.68) | 18.7374 |
1990's | 36 (22.09) | 18.2507 |
2000's | 47 (28.83) | 29.6817 |
2010's | 58 (35.58) | 24.3611 |
2020's | 16 (9.82) | 2.80 |
Authors | Studies |
---|---|
Abel, ED; Chen, B; Ciampa, G; Hall, DD; Peng, T; Shi, Q; Song, LS; Wang, J; Zheng, D | 1 |
Adams, V; Bahls, M; Baskal, S; Besler, C; Büttner, P; Knauth, S; Lurz, P; Schwedhelm, E; Thiele, H; Tsikas, D; Werner, S | 1 |
Choe, CU; Hübner, N; Jensen, M; Müller, C; Patone, G; Saar, K; Schwedhelm, E; Zeller, T | 1 |
Dehnad, A; Hajahmadi, M; Hosseini, S; Janani, L; Mofid, V; Naderi, N; Pourrajab, B; Shidfar, F; Sohouli, MH | 1 |
Alonso-Gómez, Á; Arós, F; Atzeni, A; Babio, N; Clish, CB; Corella, D; Dennis, C; Estruch, R; Fiol, M; Fitó, M; Gómez-Gracia, E; Goni, L; Guasch-Ferré, M; Hu, FB; Lapetra, J; Li, J; Liang, L; Martínez-González, MA; Razquin, C; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wittenbecher, C | 1 |
Andersson, DC; Carlström, M; Gastaldello, S; Lanner, JT; Lund, LH; Pironti, G; Rassier, DE; Westerblad, H; Yamada, T | 1 |
Lake, HA; Lygate, CA; McAndrew, DJ; Neubauer, S; Schneider, JE; Schwedhelm, E; Zervou, S | 1 |
Drohomirecka, A; Komuda, K; Lutyńska, A; Rywik, TM; Sokołowska, D; Waś, J; Wiligórska, N; Zieliński, T | 1 |
Anderson, AH; Bhat, Z; Brown, J; Brunengraber, H; Charleston, J; Chen, J; Feldman, HI; He, J; Hostetter, TH; Hsu, CY; Ix, JH; Kimmel, PL; Mehta, R; Rao, P; Sapa, H; Schelling, JR; Schrauben, SJ; Seegmiller, JC; Shafi, T; Shlipak, MG; Townsend, R; Vasan, RS; Xie, D; Zhang, X | 1 |
Böttner, J; Büttner, P; Ossmann, S; Schwedhelm, E; Thiele, H; Werner, S | 1 |
Chadwick, CC; Eckersall, PD; Fosgate, GT; French, AT; Köster, LS; Liu, M; Sanz-González, Í; Wotton, PR | 1 |
Guo, L; Lian, B; Liao, P; Lu, H; Pan, W; Zhang, M | 1 |
Contiero, B; Domenech, O; Guglielmini, C; Poser, H; Valente, C; Zini, E | 1 |
Alipoor, E; Farahbakhsh, P; Imani, H; Navid, H; Salmani, M; Yaseri, M | 1 |
Ni, S | 1 |
Baskal, S; Besler, C; Büttner, P; Lurz, P; Thiele, H; Tsikas, D; Werner, S | 1 |
Abramov, D; Birks, E; Bitar, A; Lenneman, A; Massey, T; Slaughter, M; Vijayakrishnan, R | 1 |
Azhar, G; Schutzler, SE; Smeets, ETHC; Wei, JY; Wolfe, RR | 1 |
Berghold, A; Degoricija, V; Frank, S; Meinitzer, A; Potočnjak, I; Pregartner, G; Radulović, B; Trbušić, M | 1 |
Atzler, D; Baldassarri, F; Böger, RH; Cordts, K; Düngen, HD; Duvinage, A; Edelmann, F; Halle, M; Haller, B; Hasenfuss, G; Müller, S; Pieske, B; Pressler, A; Schwedhelm, E; Suchy, C; Wachter, R | 1 |
Bondesson, U; Hedeland, M; Lundgren, J; Rådegran, G; Sandqvist, A; Wikström, G | 1 |
Chen, Y; Liu, X; Shang, R; Xu, X | 1 |
Blair, CA; Campbell, KS; Holewinski, RJ; Kirk, JA; Li, A; Martin, TG; Moravec, CS; Papadaki, M; Previs, SB; Stachowski, MJ; Van Eyk, JE; Warshaw, DM | 1 |
Araujo, NS; Claudino, MA; Nascimento, LS; Priolli, DG; Priviero, FBM; Rocha, T; Tedesco, LM | 1 |
Alexander, JH; Baran, DA; Dauerman, HL; Džavík, V; Geppert, A; Hochman, JS; Lopes, RD; Ohman, EM; Parrillo, JE; Reynolds, HR; Ruzyllo, W; Stebbins, A; van Diepen, S; Widimsky, P | 1 |
Brinkmann, SJ; Buijs, N; de Boer, MC; van Leeuwen, PA | 1 |
Atarashi, H; Kohashi, K; Kosugi, M; Kusama, Y; Morisawa, T; Nakagomi, A; Saiki, Y; Shimizu, W | 1 |
Chibbar, R; Lane, N; Ndisang, JF | 1 |
Dai, GD; Ma, P; Wang, Y; Xiong, AQ; Xu, QB; Xu, YH; Yuan, YN; Zheng, P | 1 |
Byrne, M; Gregorevic, P; Horlock, D; Joshi, M; Kaye, DM; Lam, NT; McGee, SL; Venardos, KM; Williams, D | 1 |
Batlle, M; Beltran-Alvarez, P; Brugada, R; Chiva, C; Pagans, S; Pérez-Serra, A; Pérez-Villa, F; Sabidó, E; Schulte, U; Tarradas, A | 1 |
Dai, G; Liu, J; Liu, YK; Wang, X; Wang, Y; Xu, Q; Xu, X; Zhang, J; Zhang, W | 1 |
Das, UN | 1 |
Nazari, A; Nazem, F; Ranjbar, K | 1 |
Eisel, UL; Garrelds, IM; Kop, WJ; Mommersteeg, PM; Schalkwijk, CG; Schoemaker, RG | 1 |
Adams, V; Erbs, S; Gielen, S; Hambrecht, R; Höllriegel, R; Kirsch, K; Linke, A; Lurz, P; Mangner, N; Möbius-Winkler, S; Rabald, K; Sandri, M; Schuler, G; Teupser, D; Thiery, J; Viehmann, M | 1 |
Hillebrand, J; Martens, S; Mesters, R; Scherer, M; Schmidt, C; Sindermann, J | 1 |
Caruana, E; Chevret, S; Pirracchio, R; Resche-Rigon, M | 1 |
Cheng, ML; Hsu, KH; Huang, YY; Lin, CC; Lin, JF; Liu, MH; Shiao, MS; Wang, CH | 1 |
Azhar, G; Deutz, NE; Kim, IY; Schrader, A; Schutzler, SE; Spencer, HJ; Wolfe, RR | 1 |
Blasco-Colmenares, E; Cheng, A; Dudley, SC; Guallar, E; Gutmann, R; Halder, I; Hankemeier, T; Harms, AC; London, B; Singh, M; Tomaselli, GF; Zhang, Y | 1 |
Chen, A; Chen, Y; Fassett, JT; Hou, L; Liu, X; Xu, D; Xu, Y; Yang, L; Zhuang, Y | 1 |
Nitta, D | 1 |
Choi, BS; Hyun, C; Moon, HS; Seo, SH | 1 |
Atzler, D; Boeing, H; Böger, RH; Cordts, K; di Giuseppe, R; Menzel, J; Schwedhelm, E; Weikert, C; Wirth, J | 1 |
Cottin, Y; Guenancia, C; Guilland, JC; Lorin, J; Rochette, L; Stamboul, K; Vergely, C; Zeller, M | 1 |
Altenberger, J; Dückelmann, C; Haider, DG; Mittermayer, F; Wolzt, M | 1 |
Alfieri, AB; Arioli, F; Bassanelli, G; Briceno, L; Cuko, A; Fragasso, G; Margonato, A; Montano, C; Palloshi, A; Ruotolo, G; Spoladore, R | 1 |
Greinacher, A; Haneya, A; Hirt, S; Schmid, C; Selleng, K; Selleng, S | 1 |
Yilmaz, MB; Yontar, OC | 1 |
Bing, OH; Brooks, WW; Colucci, WS; Conrad, CH; Robinson, KG | 1 |
De Pasquale, CG; Mangoni, AA; Paul, B; Whiting, MJ | 1 |
Lage, SG; Lagudis, S; Mansur, AJ; Medeiros, CC; Vieira, ML; Yamada, AT | 1 |
Lentz, SR; Murry, DJ; Rodionov, RN; Stevens, JW; Vaulman, SF | 1 |
Bettari, L; Bugatti, S; Dei Cas, A; Dei Cas, L; Kamp, O; Metra, M; Petrini, N | 1 |
Aker, S; Boengler, K; Canton, M; Deindl, E; Di Lisa, F; Heusch, G; Heusch, P; Klein, K; Konietzka, I; Menazza, S; Rassaf, T; Schulz, R; Sewell, A; van de Sand, A | 1 |
Falk, T; Guðmundsdóttir, HH; Moesgaard, SG; Olsen, LH; Rasmussen, CE; Sigurðardóttir, S; Teerlink, T | 1 |
Anker, SD; Bode-Böger, SM; Cicoira, M; Doehner, W; Genth-Zotz, S; Karhausen, T; Martens-Lobenhoffer, J; Rauchhaus, M; Schefold, JC; von Haehling, S | 1 |
Castillo-Martínez, L; Infante, O; Keirns-Davies, C; Martínez-Memije, R; Montano-Hernández, P; Orea-Tejeda, A; Orozco-Gutiérrez, JJ; Valdespino-Trejo, A; Vázquez-Díaz, O | 1 |
Davids, M; de Mol, BA; Paulus, WJ; Richir, MC; van Leeuwen, PA; Vermeulen, MA; Visser, M; Wisselink, W | 1 |
Brundiers, S; Castoldi, M; Drexler, H; Eder, M; Haghikia, A; Hilfiker-Kleiner, D; Missol-Kolka, E; Muckenthaler, MU; Petrasch-Parwez, E; Scherr, M; Stapel, B; Thum, T; Tsikas, D; Venturini, L | 1 |
Artusi, C; Cianci, V; Codognotto, M; Mion, MM; Piccoli, A; Plebani, M; Rubini, C; Vettore, G | 1 |
Carrasco-Ortiz, O; Castillo-Martínez, L; Keirns-Davis, C; Narváez-David, R; Navarro-Navarro, A; Orea-Tejeda, A; Orozco-Gutiérrez, JJ; Sánchez-Santillán, R; Valdespino-Trejo, A; Vázquez-Díaz, O | 1 |
Arnesen, H; Bratseth, V; Nilsson, BB; Seljeflot, I; Westheim, AS | 1 |
Hermansen, SE; How, OJ; Kalstad, T; Myrmel, T | 1 |
Adamopoulos, S; Constantinou, L; Haliassos, A; Karatzaferi, C; Kouretas, D; Koutedakis, Y; Kyriakides, Z; Pavlidis, P; Rentoukas, E; Tsarouhas, K; Tsitsimpikou, C; Veskoukis, A | 1 |
Bonilla, I; Cardounel, AJ; Carnes, CA; Elton, TS; Györke, S; Khan, M; Kuppusamy, P; Li, C; Nishijima, Y; Sridhar, A; Terentyev, D; Terentyeva, R; Velayutham, M; Zweier, JL | 1 |
Edo, K; Ishibashi, T; Ishikawa, K; Maruyama, Y; Ogata, H; Takahashi, T; Watanabe, M | 1 |
Aceto, A; Bucciarelli, T; Bucciarelli, V; D'Orazio, N; Di Ilio, E; Frigiola, A; Pesce, M; Riccioni, G; Scotti, L; Sorrenti, V; Speranza, L | 1 |
Bucciarelli, T; D'Orazio, N; Felaco, M; Franceschelli, S; Gaeta, R; Grilli, A; Riccioni, G; Speranza, L | 1 |
Brunini, TM; Cascarelli, PG; de Meirelles, LR; Matsuura, C; Mendes-Ribeiro, AC; Pereira, NR; Resende, Ade C; Salgado, A | 1 |
Bode-Böger, SM; Doehner, W; Ebinger, M; Endres, M; Kung, T; Liman, T; Martens-Lobenhoffer, J; Sandek, A; Scherbakov, N; Turhan, G; von Haehling, S | 1 |
Argyrakis, KS; Batika, PC; Foussas, SG; Makrygiannis, SS; Melidonis, A; Patsourakos, NG; Prekates, AA; Theodossis Georgilas, A; Tsiaousis, GZ; Tzerefos, SP; Velissaris, D; Zairis, MN | 1 |
Eno, S; Hondo, T; Iwamoto, A; Kimura, M; Matsuda, K; Matsumura, H | 1 |
Bauersachs, J; Bode-Böger, SM; Denecke, A; Kielstein, JT; Lovric, S; Martens-Lobenhoffer, J; Schieffer, B; Tutarel, O; Westhoff-Bleck, M | 1 |
Seljeflot, I | 1 |
Andersen, IA; Igumnova, E; Kildal, AB; Myrmel, T | 1 |
Chung, MY; Hsu, CP; Lin, SJ; Lu, TM | 1 |
Hartog, JW; Hillege, HL; Jaarsma, T; Roze, JF; Schalkwijk, C; van der Horst, IC; van der Meer, P; van Veldhuisen, DJ; Voors, AA; Willemsen, S | 1 |
Bucciarelli, T; Felaco, M; Franceschelli, S; Gallina, S; Patruno, A; Pesce, M; Riccioni, G; Speranza, L | 1 |
Fujii, M; Kinoshita, M; Matsumoto, T; Ohnishi, M; Takayama, T; Tsutamoto, T; Wada, A; Wang, X; Yamamoto, T | 1 |
Bellini, MA; Boschi, L; Forconi, S; Guerrini, M; Pallassini, A; Postorino, G; Richichi, MG; Trabalzini, L; Turchetti, V | 1 |
Ahlers, BA; Kaye, DM; Parnell, MM | 1 |
Zoccali, C | 1 |
Bode-Böger, SM; Fliser, D; Graf, S; Haller, H; Kielstein, JT; Klein, G | 1 |
Fyfe, DA; Mahle, WT; Todd, K | 1 |
Ball, SG; Balmforth, AJ; Cuthbert, R; de Boer, RA; Greenwood, D; Hall, AS; Maqbool, A; van Veldhuisen, DJ; White, HL | 1 |
LUCKEY, EH; OGDEN, DA; RUBIN, AL; SCHERR, L; SPRITZ, N | 1 |
GIDEKEL, LI; PETERSON, AS; SHERLOCK, P; VANAMEE, P | 1 |
GRIVAUX, M | 1 |
AKCA, L; AKMAN, N; HARMANCI, N | 1 |
Hanada, H; Ishizaka, H; Kamada, T; Matsunaga, T; Okumura, K; Osanai, T; Saitoh, M | 1 |
Klein, T; Oberhauser, V; Rump, LC; Schwertfeger, E; Stegbauer, J; Vonend, O | 1 |
Yoshimura, M | 1 |
Bednarz, B; Ceremuzyński, L; Gebalska, J; Herbaczyńska-Cedro, K; Jaxa-Chamiec, T | 1 |
Bauersachs, J; Schäfer, A | 1 |
Brunini, TM; Mendes Ribeiro, AC | 1 |
Heliö, T; Jääskeläinen, P; Kaartinen, M; Kärkkäinen, S; Kuusisto, J; Laakso, M; Miettinen, R; Nieminen, MS; Peuhkurinen, K; Reissell, E; Toivonen, L; Tuomainen, P; Ylitalo, K | 1 |
Clark, AL; Cleland, JG; Coletta, AP; Ingle, L; Lalukota, K | 1 |
Böger, R; Clark, AL; Coats, AJ; Niebauer, J; Webb-Peploe, KM | 1 |
Cheong, HI; Choi, Y; Ha, IS; Kang, HG; Kang, JH; Lee, JH; Lee, JW; Lee, SJ; Zheng, SH | 1 |
Cutrupi, S; Malatino, LS; Mallamaci, F; Tripepi, G; Zoccali, C | 1 |
Bache, RJ; Chen, Y; Hou, M; Kimoto, M; Li, Y; Traverse, JH; Xu, X; Zhang, P | 1 |
Czap, A | 1 |
Holst, DP; Kaye, DM; Parnell, MM | 1 |
Doutreleau, S; Geny, B; Lonsdorfer, J; Mettauer, B; Piquard, F; Rouyer, O; Schaefer, A | 1 |
Bykhovsy, E; Chernihovsky, T; Keren, G; Koifman, B; Megidish, R; Topilski, I; Zelmanovich, L | 1 |
Kaneko, M; Kohno, H; Muraoka, M; Shikata, H | 1 |
Brodde, OE; Philipp, T | 1 |
Arimoto, T; Hirono, O; Koyama, Y; Kubota, I; Niizeki, T; Nitobe, J; Nozaki, N; Shishido, T; Takahashi, H; Takeishi, Y; Tsunoda, Y; Watanabe, T | 1 |
Cleuren, GV; Gademan, MG; Lucas, CM; Maan, AC; Schalij, MJ; Somer, S; Swenne, CA; van de Vooren, H; van der Laarse, A; van der Wall, EE; van Exel, HJ; van Pelt, J; Verwey, HF | 1 |
Altenberger, J; Dückelmann, C; Eichinger, J; Haider, DG; Mittermayer, F; Wolzt, M | 1 |
Salinas, JL; Veverka, A | 1 |
Florkowski, CM; Frampton, CM; George, PM; Scott, RS; Sies, CW; Strey, CH; Young, JM | 1 |
Ardell, JL; Johnson, WH; Pitts, VH; Townsley, MI; Zhao, Z | 1 |
Lüscher, TF; Noll, G; Novosel, D; Tschudi, MR | 1 |
Hirai, T; Musch, TI; Zelis, R | 1 |
Blum, M; Bogomolny, N; Chernichowsky, T; Finkelstein, A; Iaina, A; Koifman, B; Laniado, S; Peer, G; Scherez, J; Wollman, Y | 1 |
Keogh, AM; Macdonald, PS; Schyvens, CG; Smythe, GA; Spratt, PM; Winlaw, DS | 1 |
Cleland, JG; Crossman, D; Dutka, D; Habib, F; Oakley, CM | 1 |
Calver, A | 1 |
Arakawa, N; Funakoshi, T; Hiramori, K; Makita, S; Nakamura, M; Yoshida, H | 1 |
Bank, AJ; Beardslee, M; Garr, MD; Kraemer, MD; Kubo, SH; Raij, L; Rector, TS; Tadros, P | 1 |
McMurray, JJ; Webb, DJ | 1 |
Ando, S; Endo, T; Hirooka, Y; Imaizumi, T; Shiramoto, M; Tagawa, T; Takeshita, A | 1 |
Brunner, HR; Drexler, H; Hayoz, D; Just, H; Münzel, T; Zelis, R | 1 |
Clozel, JP; Clozel, M; Gray, GA; Teerlink, JR | 1 |
Burnett, JC; Miller, VM; O'Murchu, B; Perrella, MA | 1 |
Drexler, H; Hornig, B; Maier, V | 1 |
Ogilvie, RI; Zborowska-Sluis, D | 1 |
Bergin, P; Chin-Dusting, JP; Jennings, GL; Kaye, DM; Lefkovits, J; Wong, J | 1 |
Chen, JJ; Cheng, JJ; Ko, YL; Kuan, P; Lien, WP; Liew, CC; Lin, SY; Liou, YC; Tang, TK; Wu, CW | 1 |
Katz, SD; Khan, T; Knecht, M; Krum, H | 1 |
Hirooka, Y; Imaizumi, T; Takeshita, A | 1 |
Forster, C; Larosa, G | 1 |
Ando, S; Imaizumi, T; Kubota, T; Oyama, J; Takeshita, A | 1 |
Stewart, DJ | 1 |
Banning, AP; Brunini, TM; Conway, M; Ellory, JC; Hanssen, H; Mann, GE; Mendes Ribeiro, AC; Roberts, NB | 1 |
Imaizumi, T; Matsuoka, H; Miyazaki, H; Okuda, S; Ueda, S; Usui, M | 1 |
Arnold, JM; Feng, Q; Fortin, AJ; Hedner, T; Kline, RL; Lu, X; Pettersson, A | 1 |
Bank, AJ; Chuang, PP; Mullen, K; Shammas, RA | 1 |
Schultz, HD; Sun, SY; Wang, W; Zucker, IH | 1 |
Hiramori, K; Kanaya, Y; Kobayashi, N; Nakamura, M | 1 |
Katz, SD; Khan, T; Knecht, M; Mathew, L; Potharlanka, P; Whelan, J; Zeballos, GA | 1 |
Arnold, JM; Arnold, O; Feng, Q; Fortin, AJ; Lu, X | 1 |
Lundberg, JM; Thorén, P; Zhang, W | 1 |
Herbaczyńska-Cedro, K | 1 |
Fonarow, GC; Hage, A; Hamilton, MA; Middlekauff, HR; Moriguchi, JD; Negrao, CE | 1 |
Doba, N; Tomiyama, H; Watanabe, G | 1 |
Erbs, S; Fiehn, E; Gielen, S; Hambrecht, R; Hilbrich, L; Schoene, N; Schuler, G | 1 |
Auler, JO; Bacal, F; Bellotti, G; Bocchi, EA; Carmona, MJ; Esteves-Filho, A; Ramires, AF; Vilella de Moraes, AV | 1 |
Chin-Dusting, JP; Prior, DL | 1 |
Banning, AP; Prendergast, B | 1 |
Gray, GA; Megson, IL; Miller, AA | 1 |
Ahlers, BA; Autelitano, DJ; Chin-Dusting, JP; Kaye, DM | 1 |
Arnold, JM; Feng, Q; Hammond, JR; Lu, X; McCormack, DG; Scott, JA; Shen, J; Stathopulos, PB | 1 |
Brunini, TM; Ellory, JC; Mann, GE; Mendes Ribeiro, AC | 1 |
Flögel, U; Gödecke, A; Heger, J; Kühn-Velten, WN; Merx, MW; Molojavyi, A; Schrader, J | 1 |
Hiraoka, Y; Kishimoto, C; Ochiai, H; Takada, H | 1 |
Brunner, HR; Drexler, H; Hayoz, D; Hornig, B; Just, H; Münzel, T; Zelis, R | 1 |
Elsner, D; Kromer, EP; Müntze, A; Riegger, GA | 1 |
Stalnikiewicz, G; Warembourg, H | 1 |
Razon-Veronesi, S | 1 |
16 review(s) available for arginine and Cardiac Failure
Article | Year |
---|---|
Prognostic Value of Asymmetric Dimethylarginine in Patients with Heart Failure: A Systematic Review and Meta-analysis.
Topics: Aged; Arginine; Heart Failure; Humans; Middle Aged; Prognosis | 2020 |
Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.
Topics: Amidohydrolases; Animals; Arginine; Endothelium, Vascular; Heart Failure; Humans; Nitric Oxide Synthase; omega-N-Methylarginine; Renal Insufficiency, Chronic; Risk Factors; Signal Transduction | 2018 |
Asymmetric dimethylarginine and critical illness.
Topics: Amidohydrolases; Arginine; Critical Illness; Enzyme Inhibitors; Heart Failure; Humans; Intensive Care Units; Nitric Oxide; Nitric Oxide Synthase; Risk Factors | 2014 |
Nutritional factors in the prevention and management of coronary artery disease and heart failure.
Topics: Alprostadil; Anti-Inflammatory Agents; Arginine; CD59 Antigens; Coronary Artery Disease; Diabetes Mellitus, Type 2; Epoprostenol; Fatty Acids, Essential; Fatty Acids, Unsaturated; Female; Folic Acid; Heart Failure; Humans; Hypertension; Lipoxins; Magnesium; Male; Middle Aged; Nitric Oxide; Nutritional Status; Serum Albumin; Vasodilation; Vitamin B 12; Vitamin B 6 | 2015 |
Effect of asymmetric dimethylarginine (ADMA) on heart failure development.
Topics: Amidohydrolases; Animals; Arginine; Heart Failure; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peroxynitrous Acid; Signal Transduction; Superoxides | 2016 |
The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.
Topics: Amidohydrolases; Arginine; Citrulline; Coronary Vessels; Glutamic Acid; Heart Failure; Humans; Nitric Oxide; Reactive Oxygen Species | 2010 |
[Heart failure in patients with hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Arginine; Chronic Disease; Diagnosis, Differential; Diuretics; Drug Therapy, Combination; Endothelin-1; Heart Failure; Humans; Hypertension; Prognosis; Renin-Angiotensin System; Vasopressins | 2004 |
Endothelial dysfunction in heart failure: mechanisms and therapeutic approaches.
Topics: Animals; Antioxidants; Arginine; Biopterins; Disease Models, Animal; Endothelins; Endothelium, Vascular; Exercise; Genetic Therapy; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Renin-Angiotensin System | 2004 |
L-Arginine transport in disease.
Topics: Amino Acid Transport Systems, Basic; Anemia, Sickle Cell; Arginine; Biological Transport; Diabetes Mellitus; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Nitric Oxide; Shock, Septic | 2004 |
Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine; Cardiotonic Agents; Cardiovascular Agents; Crataegus; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Homozygote; Humans; Oxygen Consumption; Plant Extracts; Propanolamines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-1; Societies, Medical; Stroke Volume; Survival Analysis; Treatment Failure; Treatment Outcome; United States | 2004 |
[Role of the L-arginine/nitric oxide system in the action of nebivolol].
Topics: Adrenergic beta-Antagonists; Arginine; Benzopyrans; Coronary Disease; Ethanolamines; Heart Failure; Humans; Hypertension; Nebivolol; Nitric Oxide; Receptors, Adrenergic, beta; Sympathetic Nervous System; Vasodilator Agents | 2006 |
Effect of exercise training on autonomic derangement and neurohumoral activation in chronic heart failure.
Topics: Arginine; Autonomic Nervous System Diseases; Baroreflex; Catecholamines; Chronic Disease; Endothelins; Exercise Therapy; Heart Failure; Heart Rate; Humans; Natriuretic Peptide, Brain; Neurotransmitter Agents; Renin-Angiotensin System; Treatment Outcome; Vasopressins | 2007 |
Nebivolol in the treatment of chronic heart failure.
Topics: Arginine; Benzopyrans; Chronic Disease; Drug Tolerance; Ethanolamines; Heart Failure; Humans; Nebivolol; Nitric Oxide | 2007 |
Endothelial dysfunction in chronic heart failure. Experimental and clinical studies.
Topics: Arginine; Chronic Disease; Endothelium, Vascular; Heart Failure; Humans; In Vitro Techniques; Nitric Oxide; omega-N-Methylarginine | 1994 |
Positive and negative outcomes of L-arginine therapy in cardiovascular diseases.
Topics: Arginine; Arterial Occlusive Diseases; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Heart Failure; Humans; Hyperlipidemias; Myocardial Ischemia; Nitric Oxide; Treatment Outcome | 1999 |
Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure.
Topics: Animals; Arginine; Biological Transport; Blood Platelets; Cytokines; Endothelium, Vascular; Erythrocytes; Heart Failure; Humans; Kidney Failure, Chronic; Models, Animal; Nitric Oxide; Signal Transduction; Uremia | 2001 |
29 trial(s) available for arginine and Cardiac Failure
Article | Year |
---|---|
The impact of probiotic yogurt versus ordinary yogurt on serum sTWEAK, sCD163, ADMA, LCAT and BUN in patients with chronic heart failure: a randomized, triple-blind, controlled trial.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Arginine; Blood Urea Nitrogen; Cytokine TWEAK; Heart Failure; Humans; Phosphatidylcholine-Sterol O-Acyltransferase; Probiotics; Receptors, Cell Surface; Tumor Necrosis Factor-alpha; Yogurt | 2022 |
Effect of l-arginine on cardiac reverse remodeling and quality of life in patients with heart failure.
Topics: Arginine; Blood Pressure; Dietary Supplements; Double-Blind Method; Echocardiography; Female; Heart; Heart Failure; Humans; Iran; Male; Middle Aged; Quality of Life; Stroke Volume; Surveys and Questionnaires; Ventricular Function, Left; Walk Test | 2021 |
Do anabolic nutritional supplements stimulate human growth hormone secretion in elderly women with heart failure?
Topics: Aged; Aged, 80 and over; Anabolic Agents; Arginine; Dietary Supplements; Female; Heart Failure; Human Growth Hormone; Humans; Lysine | 2017 |
Relationship between exercise intervention and NO pathway in patients with heart failure with preserved ejection fraction.
Topics: Aged; Arginine; Biomarkers; Exercise Therapy; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; Prospective Studies; Signal Transduction; Stroke Volume | 2018 |
Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Arginine; Double-Blind Method; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Renin-Angiotensin System; Shock, Cardiogenic; Time Factors; Treatment Outcome | 2014 |
Chronic heart failure and aging - effects of exercise training on endothelial function and mechanisms of endothelial regeneration: Results from the Leipzig Exercise Intervention in Chronic heart failure and Aging (LEICA) study.
Topics: Aged; Aging; Arginine; Blood Flow Velocity; Cell Count; Chemokine CXCL12; Endothelial Progenitor Cells; Endothelium, Vascular; Exercise Therapy; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Prospective Studies; Radial Artery; Regeneration; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2016 |
Acute effects of 5-methyltetrahydrofolate on endothelial function and asymmetric dimethylarginine in patients with chronic heart failure.
Topics: Aged; Arginine; Chronic Disease; Endothelium, Vascular; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Tetrahydrofolates | 2010 |
The effect of dobutamine without and with L-arginine on arterial compliance in heart failure patients.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Brachial Artery; Dobutamine; Drug Therapy, Combination; Elastic Modulus; Elasticity Imaging Techniques; Female; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2009 |
Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol.
Topics: Aged; Allopurinol; Arginine; Chronic Disease; Citrulline; Cross-Sectional Studies; Double-Blind Method; Female; Free Radical Scavengers; Heart Failure; Humans; Male; Middle Aged; Reactive Oxygen Species; Uric Acid; Vasodilation | 2010 |
The effect of L-arginine and citrulline on endothelial function in patients in heart failure with preserved ejection fraction.
Topics: Aged; Arginine; Citrulline; Echocardiography; Endothelium, Vascular; Female; Fingers; Heart Failure; Heart Failure, Diastolic; Humans; Male; Middle Aged; Photoplethysmography; Stroke Volume; Vasodilation | 2010 |
Effect of L-arginine or L-citrulline oral supplementation on blood pressure and right ventricular function in heart failure patients with preserved ejection fraction.
Topics: Administration, Oral; Aged; Arginine; Blood Pressure; Chi-Square Distribution; Citrulline; Dietary Supplements; Echocardiography, Doppler; Exercise Test; Female; Heart Failure; Humans; Male; Mexico; Middle Aged; Pulmonary Artery; Radionuclide Ventriculography; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Right | 2010 |
Effects of walking on heart rate recovery, endothelium modulators and quality of life in patients with heart failure.
Topics: Aged; Analysis of Variance; Arginine; Biomarkers; Chronic Disease; Endothelium, Vascular; Exercise Therapy; Female; Greece; Heart Failure; Heart Rate; Homocysteine; Humans; Inflammation Mediators; Male; Middle Aged; Oxidative Stress; Quality of Life; Recovery of Function; Surveys and Questionnaires; Time Factors; Treatment Outcome; Walking | 2011 |
The biological evaluation of ADMA/SDMA and eNOS in patients with ACHF.
Topics: Adult; Aged; Alanine Transaminase; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine; Aspartate Aminotransferases; Blotting, Western; Chromatography, High Pressure Liquid; Digoxin; Diuretics; Echocardiography; Electron Transport Complex IV; Female; Heart Failure; Humans; Kidney Function Tests; Leukocytes, Mononuclear; Male; Middle Aged; Nitric Oxide Synthase Type III; Oxygen | 2013 |
Reduced myocardial and systemic L-arginine uptake in heart failure.
Topics: Arginine; Biological Transport; Biopsy; Cardiac Output; Catheterization; Cationic Amino Acid Transporter 1; Cationic Amino Acid Transporter 2; Chronic Disease; Citrulline; Down-Regulation; Heart Failure; Heart Ventricles; Humans; Infusions, Intravenous; Kinetics; Metabolic Clearance Rate; Middle Aged; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Reference Values; RNA, Messenger; Tritium | 2002 |
L-arginine supplementation prolongs exercise capacity in congestive heart failure.
Topics: Aged; Arginine; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome; Vasodilator Agents | 2004 |
Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure.
Topics: Adult; Arginine; Cross-Over Studies; Exercise; Female; Heart Failure; Humans; Hypoxanthine; Male; Middle Aged; Nitrates; Nitrites; Xanthine | 2005 |
Augmentation of endothelial function following exercise training is associated with increased L-arginine transport in human heart failure.
Topics: Acetylcholine; Analysis of Variance; Arginine; Biological Transport; Case-Control Studies; Endothelium, Vascular; Exercise Tolerance; Forearm; Heart Failure; Humans; Male; Metabolic Clearance Rate; Middle Aged; Myocardium; Nitroprusside; Physical Education and Training; Regional Blood Flow; Vasodilator Agents | 2005 |
Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure.
Topics: Arginine; Atorvastatin; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Ventricular Dysfunction, Left | 2008 |
Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure.
Topics: Aged; Arginine; Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Nitrates; Nitrites | 1995 |
Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure.
Topics: Acetylcholine; Arginine; Aspirin; Enalaprilat; Endothelium, Vascular; Female; Forearm; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Plethysmography; Premedication; Vasodilation | 1994 |
Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure.
Topics: Adult; Arginine; Arteries; Diet; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Vascular Resistance | 1996 |
Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure.
Topics: Arginine; Echocardiography; Enzyme Inhibitors; Female; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II | 1998 |
Effects of short-term forearm exercise training on resistance vessel endothelial function in normal subjects and patients with heart failure.
Topics: Acetylcholine; Adult; Aged; Aged, 80 and over; Analysis of Variance; Arginine; Brachial Artery; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Exercise; Exercise Therapy; Female; Forearm; Hand Strength; Heart Failure; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Muscle Contraction; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Vascular Resistance; Vasodilation; Vasodilator Agents | 1998 |
Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure.
Topics: Adult; Aged; Arginine; Biomarkers; Case-Control Studies; Cross-Over Studies; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Leg; Male; Middle Aged; Plethysmography; Regional Blood Flow; Single-Blind Method; Vasodilation | 1999 |
Effects of oral administration of L-arginine on renal function in patients with heart failure.
Topics: Administration, Oral; Adult; Aged; Arginine; Cross-Over Studies; Double-Blind Method; Endothelins; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Male; Middle Aged; Natriuresis | 2000 |
Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation.
Topics: Acetylcholine; Administration, Oral; Aged; Arginine; Blood Flow Velocity; Endothelium, Vascular; Exercise Therapy; Heart Failure; Humans; Injections, Intra-Arterial; Male; Middle Aged; Nitroglycerin; Radial Artery; Stroke Volume; Treatment Outcome; Ultrasonography, Doppler; Vasodilation; Vasodilator Agents | 2000 |
Transient improvement of acetylcholine responses after short-term oral L-arginine in forearms of human heart failure.
Topics: Acetylcholine; Administration, Oral; Adult; Analysis of Variance; Arginine; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Forearm; Heart Failure; Humans; Ischemia; Male; Middle Aged; Nitrates; Nitrites; Nitroprusside; Norepinephrine; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Intravenous L-arginine reduces VE/VCO2 slope acutely in patients with severe chronic heart failure.
Topics: Arginine; Blood Pressure; Breath Tests; Carbon Dioxide; Chronic Disease; Cross-Over Studies; Exercise Test; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Nifedipine; Prognosis; Pulmonary Gas Exchange; Severity of Illness Index; Single-Blind Method; Vasodilator Agents | 1999 |
In vivo and in vitro evidence for impaired arginine transport in human heart failure.
Topics: Adult; Amino Acid Transport Systems, Basic; Arginine; Biological Transport; Carrier Proteins; Forearm; Gene Expression Regulation; Heart Failure; Humans; Leukocytes, Mononuclear; Membrane Proteins; Middle Aged; Regional Blood Flow; RNA, Messenger; Time Factors; Tritium | 2000 |
118 other study(ies) available for arginine and Cardiac Failure
Article | Year |
---|---|
Calpain-2 specifically cleaves Junctophilin-2 at the same site as Calpain-1 but with less efficacy.
Topics: Animals; Arginine; Calpain; Disease Models, Animal; Glycine; Heart Failure; HEK293 Cells; Humans; Male; Membrane Proteins; Mice; Muscle Proteins; Mutagenesis, Site-Directed; Myocytes, Cardiac; Proteolysis; Signal Transduction; Threonine; Transfection | 2021 |
Arginine metabolism and nitric oxide turnover in the ZSF1 animal model for heart failure with preserved ejection fraction.
Topics: Animals; Arginase; Arginine; Disease Models, Animal; Female; Heart; Heart Failure; Kidney; Male; Metabolic Syndrome; Myocardium; Nitric Oxide; Obesity; Rats; Stroke Volume; Thinness; Ventricular Function, Left | 2021 |
Expression of cardiovascular-related microRNAs is altered in L-arginine:glycine amidinotransferase deficient mice.
Topics: Amidinotransferases; Animals; Arginine; Creatine; Heart Failure; Homoarginine; Mice; MicroRNAs; Myocardial Infarction | 2022 |
Arginine catabolism metabolites and atrial fibrillation or heart failure risk: 2 case-control studies within the Prevención con Dieta Mediterránea (PREDIMED) trial.
Topics: Arginine; Atrial Fibrillation; Cardiovascular Diseases; Case-Control Studies; Diet, Mediterranean; Heart Failure; Humans; Mediterranea; Risk Factors | 2022 |
Citrullination is linked to reduced Ca
Topics: Actins; Animals; Arginine; Arthritis, Experimental; Arthritis, Rheumatoid; Citrullination; Citrulline; Disease Models, Animal; Heart Failure; Hydrolases; Mice; Protein-Arginine Deiminases; Tumor Necrosis Factor-alpha | 2022 |
Homoarginine and creatine deficiency do not exacerbate murine ischaemic heart failure.
Topics: Animals; Arginine; Creatine; Female; Heart Failure; Homoarginine; Humans; Mice; Myocardial Infarction; Myocardium | 2023 |
L-arginine and Its Derivatives Correlate with Exercise Capacity in Patients with Advanced Heart Failure.
Topics: Arginine; Biomarkers; Exercise Tolerance; Heart Failure; Heart Transplantation; Humans; Vascular Diseases | 2023 |
Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
Topics: Arginine; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Diabetic Nephropathies; Heart Failure; Humans; Renal Insufficiency, Chronic | 2023 |
Systemic Effects of Homoarginine Supplementation on Arginine Metabolizing Enzymes in Rats with Heart Failure with Preserved Ejection Fraction.
Topics: Animals; Arginine; Dietary Supplements; Heart Failure; Homoarginine; Rats; Stroke Volume | 2023 |
Cardiovascular-renal axis disorder and acute-phase proteins in cats with congestive heart failure caused by primary cardiomyopathy.
Topics: Acute-Phase Proteins; Animals; Arginine; Biomarkers; Cardiomyopathies; Case-Control Studies; Cat Diseases; Cats; Creatinine; Female; Heart Failure; Inflammation; Kidney Diseases; Male; Natriuretic Peptide, Brain; Peptide Fragments | 2020 |
Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
Topics: Animals; Arginine; Biomarkers; Case-Control Studies; Dog Diseases; Dogs; Echocardiography; Female; Heart Failure; Heart Valve Diseases; Hypertension, Pulmonary; Male; Mitral Valve; Mitral Valve Insufficiency; Mitral Valve Prolapse; Retrospective Studies; Severity of Illness Index | 2020 |
Effect of l-arginine on cardiac reverse remodeling and quality of life in patients with heart failure.
Topics: Arginine; Heart; Heart Failure; Humans; Quality of Life | 2021 |
Profile of urinary amino acids and their post-translational modifications (PTM) including advanced glycation end-products (AGEs) of lysine, arginine and cysteine in lean and obese ZSF1 rats.
Topics: Animals; Arginine; Creatinine; Cysteine; Glucose; Glycation End Products, Advanced; Heart Failure; Lysine; Obesity; Protein Processing, Post-Translational; Rats; Stroke Volume | 2022 |
The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices.
Topics: Adult; Aged; Anticoagulants; Arginine; Eptifibatide; Female; Heart Failure; Heart-Assist Devices; Hemolysis; Heparin; Humans; Male; Middle Aged; Peptides; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Sulfonamides; Thrombosis; Warfarin; Young Adult | 2017 |
Serum concentrations of asymmetric and symmetric dimethylarginine are associated with mortality in acute heart failure patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Arginine; Biomarkers; Cohort Studies; Female; Heart Failure; Humans; Male; Mortality; Stroke Volume | 2018 |
Alterations in plasma L-arginine and methylarginines in heart failure and after heart transplantation.
Topics: Arginine; Biomarkers; Citrulline; Endothelium, Vascular; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Male; Middle Aged; Nitric Oxide; Ornithine; Prospective Studies; Time Factors; Treatment Outcome | 2018 |
Diabetes with heart failure increases methylglyoxal modifications in the sarcomere, which inhibit function.
Topics: Actins; Adult; Animals; Arginine; Cardiomyopathy, Dilated; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Glycolysis; Heart Failure; Heart Ventricles; Humans; Lysine; Male; Mice; Middle Aged; Myosins; Pyruvaldehyde; Sarcomeres; Single-Cell Analysis | 2018 |
Molecular evidence of tissue remodeling in an animal model of heart failure.
Topics: Animals; Aorta; Arginine; Biomarkers; Disease Models, Animal; Extracellular Matrix; Fibrosis; Fistula; Heart; Heart Failure; Immunohistochemistry; Male; Matrix Metalloproteinase 9; Myocardium; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1 | 2019 |
Effects of eicosapentaenoic acid on the levels of inflammatory markers, cardiac function and long-term prognosis in chronic heart failure patients with dyslipidemia.
Topics: Aged; Arginine; Biomarkers; Chemokine CCL2; Chromatography, High Pressure Liquid; Chronic Disease; Dyslipidemias; Eicosapentaenoic Acid; Female; Follow-Up Studies; Heart Failure; Humans; Inflammation Mediators; Male; Prognosis; Survival Rate; Ventricular Function, Left | 2014 |
Heme oxygenase suppresses markers of heart failure and ameliorates cardiomyopathy in L-NAME-induced hypertension.
Topics: Adiponectin; Aldosterone; Animals; Antioxidants; Arginine; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cardiomyopathies; Cardiotonic Agents; Chemokine CCL2; Chemokine CCL3; Cyclic GMP; Dinoprost; Endothelin-1; Enzyme Induction; Extracellular Matrix Proteins; Heart Failure; Heme; Heme Oxygenase (Decyclizing); Hypertension; Interleukin-1beta; Interleukin-6; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tyrosine | 2014 |
[Protective effect of oxymatrine on chronic heart failure and ADMA metabolism pathway in isoproterenol-induced chronic heart failure in rats].
Topics: Alkaloids; Amidohydrolases; Animals; Arginine; Chronic Disease; Gene Expression Regulation, Enzymologic; Heart Failure; Hemodynamics; Isoproterenol; Male; Organ Size; Quinolizines; Rats; Rats, Sprague-Dawley; Troponin I | 2014 |
Abnormal mitochondrial L-arginine transport contributes to the pathogenesis of heart failure and rexoygenation injury.
Topics: Animals; Arginine; Biological Transport; Gene Expression Regulation; Heart Failure; Heart Injuries; Mice; Mitochondria, Heart; Myocytes, Cardiac; Nitric Oxide; Oxidative Stress; Oxygen; Sheep; TRPV Cation Channels | 2014 |
Identification of N-terminal protein acetylation and arginine methylation of the voltage-gated sodium channel in end-stage heart failure human heart.
Topics: Acetylation; Amino Acid Sequence; Arginine; Cardiomyopathy, Dilated; Heart Failure; Humans; Methylation; Myocardial Ischemia; Myocardium; NAV1.5 Voltage-Gated Sodium Channel; Protein Processing, Post-Translational | 2014 |
Cardioprotective effects of oxymatrine on isoproterenol-induced heart failure via regulation of DDAH/ADMA metabolism pathway in rats.
Topics: Alkaloids; Amidohydrolases; Animals; Arginine; Cardiotonic Agents; Disease Models, Animal; Female; Heart Failure; Hemodynamics; Isoproterenol; Male; Metabolic Networks and Pathways; Myocardium; Natriuretic Peptide, Brain; Organ Size; Protein-Arginine N-Methyltransferases; Quinolizines; Rats; Rats, Sprague-Dawley; Troponin I | 2014 |
Effect of Exercise Training and L-arginine on Oxidative Stress and Left Ventricular Function in the Post-ischemic Failing Rat Heart.
Topics: Animals; Arginine; Combined Modality Therapy; Heart Failure; Male; Myocardial Ischemia; Oxidative Stress; Physical Conditioning, Animal; Rats; Rats, Wistar; Ventricular Function, Left | 2016 |
Nitric oxide dysregulation in patients with heart failure: the association of depressive symptoms with L-arginine, asymmetric dimethylarginine, symmetric dimethylarginine, and isoprostane.
Topics: Aged; Arginine; Depression; Female; Heart Failure; Humans; Isoprostanes; Linear Models; Male; Middle Aged; Nitric Oxide; Oxidative Stress | 2015 |
Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia.
Topics: Acute Disease; Adult; Aged; Anticoagulants; Arginine; Cohort Studies; Extracorporeal Circulation; Female; Heart Failure; Heart-Assist Devices; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Prosthesis Implantation; Sulfonamides; Thrombocytopenia; Thrombosis | 2015 |
A new weighted balance measure helped to select the variables to be included in a propensity score model.
Topics: Acute Disease; Arginine; Bias; Cohort Studies; Computer Simulation; Continuous Positive Airway Pressure; Data Collection; France; Heart Failure; Hospital Mortality; Humans; Intensive Care Units; Mean Platelet Volume; Models, Statistical; Monte Carlo Method; Observational Studies as Topic; Outcome Assessment, Health Care; Pipecolic Acids; Propensity Score; Sulfonamides | 2015 |
Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Case-Control Studies; Chi-Square Distribution; Chromatography, Liquid; Cresols; Female; Heart Failure; Humans; Indican; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Reproducibility of Results; Risk Factors; Spectrometry, Mass, Electrospray Ionization; Sulfuric Acid Esters; Time Factors; Up-Regulation; Young Adult | 2016 |
Acute ingestion of citrulline stimulates nitric oxide synthesis but does not increase blood flow in healthy young and older adults with heart failure.
Topics: Adult; Aged; Arginine; Cardiovascular Agents; Citrulline; Dietary Supplements; Elder Nutritional Physiological Phenomena; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Hyperemia; Kinetics; Male; Middle Aged; Nitric Oxide; Regional Blood Flow; Severity of Illness Index; Up-Regulation; Young Adult | 2015 |
Serum amine-based metabolites and their association with outcomes in primary prevention implantable cardioverter-defibrillator patients.
Topics: Aged; Amines; Arginine; Biomarkers; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Heart Failure; Humans; Kynurenine; Male; Metabolomics; Methylhistidines; Middle Aged; Predictive Value of Tests; Primary Prevention; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; United States | 2016 |
Predictors for Tolvaptan Treatment and Future Perspectives.
Topics: Aldosterone; Antidiuretic Hormone Receptor Antagonists; Arginine; Benzazepines; Biomarkers; Diuresis; Dose-Response Relationship, Drug; Evidence-Based Medicine; Heart Failure; Humans; Predictive Value of Tests; Prognosis; Renin-Angiotensin System; Sensitivity and Specificity; Severity of Illness Index; Tolvaptan; Treatment Outcome; Vasopressins | 2016 |
Evaluation of serum cystatin-C and symmetric dimethylarginine concentrations in dogs with heart failure from chronic mitral valvular insufficiency.
Topics: Animals; Arginine; Biomarkers; Blood Urea Nitrogen; Creatinine; Cystatin C; Dog Diseases; Dogs; Glomerular Filtration Rate; Heart Failure; Mitral Valve Insufficiency | 2017 |
Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study.
Topics: Adult; Aged; Arginine; Biomarkers; Feeding Behavior; Female; Germany; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Proportional Hazards Models; Prospective Studies; Risk | 2017 |
Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction.
Topics: Aged; Arginine; Female; Glomerular Filtration Rate; Heart Failure; Hospitals; Humans; Male; Middle Aged; Myocardial Infarction; Nitric Oxide; Prognosis; Renal Insufficiency, Chronic; Treatment Outcome; Ventricular Function, Left | 2017 |
Plasma asymmetric dimethylarginine and cardiovascular events in patients with acute decompensated heart failure.
Topics: Aged; Arginine; Austria; Cohort Studies; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Risk Assessment; Ventricular Dysfunction, Left | 2008 |
Differential long-term effects of carvedilol on proinflammatory and antiinflammatory cytokines, asymmetric dimethylarginine, and left ventricular function in patients with heart failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Arginine; Carbazoles; Carvedilol; Cytokines; Drug Administration Schedule; Female; Heart Failure; Humans; Interleukin-10; Interleukin-18; Male; Propanolamines; Prospective Studies; Ventricular Function, Left | 2008 |
Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation.
Topics: Adult; Anticoagulants; Arginine; Autoantibodies; Heart Failure; Heart Transplantation; Heparin; Hirudins; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2008 |
Smoker's paradox in heart failure: might asymmetric dimethylarginine be the possible explanation?
Topics: Arginine; Cardiovascular Diseases; Heart Failure; Hospital Mortality; Humans; Smoking | 2008 |
L-arginine fails to prevent ventricular remodeling and heart failure in the spontaneously hypertensive rat.
Topics: Animals; Arginine; Captopril; Cardiomegaly; Heart; Heart Failure; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Remodeling | 2009 |
Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production.
Topics: Adenoviridae; Animals; Arginine; Atherosclerosis; Chlorocebus aethiops; Citrulline; COS Cells; Diabetes Mellitus; Endothelial Cells; Gene Expression; Heart Failure; Humans; Hydrolysis; Hypertension; Kidney; Liver; Mice; Mitochondria; Nitric Oxide; Nitric Oxide Synthase; Transaminases; Transduction, Genetic | 2010 |
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Benzopyrans; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Endothelium, Vascular; Ethanolamines; Exercise Tolerance; Heart Failure; Heart Rate; Hemodynamics; Humans; Hypertension; Nebivolol; Nitric Oxide; Stroke Volume; Vascular Resistance; Vasodilation; Vasodilator Agents | 2010 |
Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation.
Topics: Animals; Arginase; Arginine; Blotting, Western; Cardiac Pacing, Artificial; Disease Models, Animal; Enzyme Inhibitors; Heart Failure; Heart Rate; Imines; Male; Microscopy, Confocal; Myocardial Contraction; Myocardium; Nitrates; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Protein Processing, Post-Translational; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stroke Volume; Superoxides; Up-Regulation; Ventricular Function, Left | 2010 |
Brain-natriuretic peptide and cyclic guanosine monophosphate as biomarkers of myxomatous mitral valve disease in dogs.
Topics: Age Factors; Animals; Arginine; Biomarkers; Cyclic GMP; Dog Diseases; Dogs; Echocardiography; Female; Heart Failure; Heart Valve Diseases; Male; Mitral Valve; Mitral Valve Insufficiency; Natriuretic Peptide, Brain; Peptide Fragments | 2011 |
Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes.
Topics: Animals; Arginine; Down-Regulation; Endothelial Cells; Endothelium, Vascular; Heart Failure; Humans; Mice; Mice, Knockout; MicroRNAs; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Rats; STAT3 Transcription Factor; Ubiquitin-Conjugating Enzymes; Up-Regulation | 2011 |
Determinants of circulating asymmetric and symmetric dimethylarginines in patients evaluated for acute dyspnea.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Arginine; Biomarkers; Dyspnea; Female; Heart Failure; Humans; Kidney; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Regression Analysis | 2011 |
The L-arginine-asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training.
Topics: Aged; Aged, 80 and over; Arginine; Endothelium, Vascular; Exercise Therapy; Exercise Tolerance; Female; Flow Cytometry; Health Status Indicators; Heart Failure; Humans; Leukocytes; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide Synthase; Peptide Fragments; Reactive Oxygen Species; Severity of Illness Index; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2011 |
Inflammation and reduced endothelial function in the course of severe acute heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Arginine; Biomarkers; Case-Control Studies; Endothelium, Vascular; Female; Heart Failure; Humans; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-6; Interleukin-8; Male; Middle Aged; Prospective Studies; Shock, Cardiogenic; Vascular Cell Adhesion Molecule-1; Vasodilation | 2011 |
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology.
Topics: Action Potentials; Animals; Arginine; Atrial Fibrillation; Atrial Function, Left; Biopterins; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Female; Heart Atria; Heart Failure; Kinetics; Male; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Patch-Clamp Techniques; Superoxides; Up-Regulation; Ventricular Function, Left | 2011 |
Effects of oral supplementation of L-arginine in the treatment of pulmonary hypertension secondary to pulmonary embolism: a case report.
Topics: Administration, Oral; Arginine; Dietary Supplements; Female; Heart Failure; Humans; Hypertension, Pulmonary; Middle Aged; Natriuretic Peptide, Brain; Pulmonary Embolism | 2010 |
The effect of pharmacological treatment on ADMA in patients with heart failure.
Topics: Aged; Arginine; Female; Heart Failure; Humans; Male; Middle Aged | 2011 |
The biological effect of pharmacological treatment on dimethylaminohydrolases (DDAH-1) and cationic amino acid transporter-1 (CAT-1) expression in patients with acute congestive heart failure.
Topics: Acute Disease; Aged; Amidohydrolases; Arginine; Cardiovascular Agents; Cationic Amino Acid Transporter 1; Chromatography, High Pressure Liquid; Echocardiography, Doppler; Female; Heart Failure; Humans; Italy; Male; Middle Aged; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2011 |
Platelet activation, oxidative stress and overexpression of inducible nitric oxide synthase in moderate heart failure.
Topics: Adenosine Diphosphate; Arginine; Blood Platelets; C-Reactive Protein; Case-Control Studies; Collagen; Female; Fibrinogen; Heart Failure; Humans; Inflammation; Male; Middle Aged; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Platelet Activation; Platelet Aggregation; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2011 |
Endothelial dysfunction of the peripheral vascular bed in the acute phase after ischemic stroke.
Topics: Aged; Analysis of Variance; Arginine; Biomarkers; Blood Pressure; Case-Control Studies; Endothelium, Vascular; Female; Fingers; Forearm; Germany; Heart Failure; Humans; Hyperemia; Infarction, Middle Cerebral Artery; Linear Models; Male; Middle Aged; Plethysmography; Severity of Illness Index; Time Factors; Up-Regulation; Vasodilation | 2012 |
Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure.
Topics: Aged; Arginine; Biomarkers; Endothelium, Vascular; Enzyme Inhibitors; Female; Follow-Up Studies; Greece; Heart Failure; Hospitals, University; Humans; Incidence; Inpatients; Kaplan-Meier Estimate; Length of Stay; Male; Predictive Value of Tests; Prognosis; Risk Assessment; Sensitivity and Specificity; Stroke Volume; Survival Rate | 2012 |
A case of acute coronary artery occlusion associated with very rapid onset heparin-induced thrombosis without thrombocytopenia.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Aspirin; Autoantibodies; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Occlusion; Drug Therapy, Combination; Female; Heart Failure; Heparin; Humans; Pipecolic Acids; Platelet Count; Platelet Factor 4; Stents; Sulfonamides; Tetrazoles; Thrombosis; Ticlopidine; Time Factors | 2012 |
Asymmetrical dimethylarginine--more sensitive than NT-proBNP to diagnose heart failure in adults with congenital heart disease.
Topics: Adult; Arginine; Biomarkers; Cross-Sectional Studies; Echocardiography; Exercise Test; Female; Heart Defects, Congenital; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Peptide Fragments; ROC Curve; Ventricular Dysfunction, Left; Young Adult | 2012 |
Plasma asymmetric dimethylarginine in patients with acute decompensation of chronic heart failure.
Topics: Arginine; Enzyme Inhibitors; Female; Heart Failure; Humans; Male | 2012 |
Reassessment of a suggested pharmacological approach to heart failure: L-arginine is only a marginal NO donor in pigs.
Topics: Animals; Arginine; Female; Heart Failure; Infusions, Intravenous; Male; Myocardial Reperfusion Injury; Nitric Oxide Donors; Sus scrofa; Ventricular Dysfunction, Left | 2012 |
Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Chi-Square Distribution; Chromatography, High Pressure Liquid; Coronary Angiography; Disease-Free Survival; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Stroke Volume; Taiwan; Time Factors; Ultrasonography; Up-Regulation; Ventricular Function, Left | 2012 |
The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Female; Glycation End Products, Advanced; Heart Failure; Humans; Kaplan-Meier Estimate; Lysine; Male; Mass Spectrometry; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Stroke Volume | 2012 |
Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
Topics: Animals; Arginine; Cardiac Output; Cardiac Pacing, Artificial; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Heart Failure; Models, Animal; Nitric Oxide Synthase; Pyrimidines; Random Allocation; Receptor, Endothelin A; Sulfonamides; Vascular Resistance | 2002 |
Haemorheological and endothelial-dependent alterations in heart failure after ACE inhibitor, calcium antagonist and beta blocker.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Arginine; Blood Viscosity; Calcium; Carbazoles; Carvedilol; Citrulline; Erythrocytes; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide Synthase; Propanolamines; Ramipril; Time Factors; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Vasodilator Agents | 2002 |
ADMA: a critical cardio-renal link in heart failure?
Topics: Arginine; Heart Failure; Humans; Kidney Failure, Chronic; Nitric Oxide | 2003 |
Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure.
Topics: Aged; Arginine; Endothelium, Vascular; Heart Failure; Humans; Kidney Diseases; Male; Renal Circulation; Vasodilation | 2003 |
Endothelial function following the Fontan operation.
Topics: Arginine; Blood Pressure; Brachial Artery; Case-Control Studies; Child; Endothelium, Vascular; Fontan Procedure; Heart Defects, Congenital; Heart Failure; Heart Rate; Heart Ventricles; Humans; Nitric Oxide; Postoperative Period; Regional Blood Flow; Ultrasonography; Vasodilation | 2003 |
An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study.
Topics: Adrenergic beta-Antagonists; Aged; Arginine; Blood Pressure; Female; Genotype; Glycine; Heart Failure; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-1 | 2003 |
The management of resistant fluid-retention states with intravenous L-arginine monohydrochloride in combination with mercurial diuretics.
Topics: Arginine; Disease Management; Diuretics; Edema; Heart Failure; Humans; Organomercury Compounds | 1961 |
Management of refractory fluid retention with a combination of L-arginine monohydrochloride and mercurials.
Topics: Acid-Base Imbalance; Arginine; Disease Management; Diuretics; Edema; Heart Failure; Organomercury Compounds | 1960 |
[Indications and results of L-arginine HCl in hepatic and cardiac pathology].
Topics: Arginine; Heart; Heart Failure; Liver Diseases | 1961 |
[ON THE CLINICAL USE OF A NEW AGENT RENDERING THE MERCURIAL DIURETICS EFFECTIVE, IN CASES OF FLUID RETENTION RESISTANT TO TREATMENT].
Topics: Arginine; Ascites; Diuretics; Heart Failure; Liver Cirrhosis; Organomercury Compounds; Water-Electrolyte Imbalance | 1963 |
High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level.
Topics: Acute Disease; Arginine; Chromatography, High Pressure Liquid; Chronic Disease; Cytokines; Enzyme Inhibitors; Female; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Tumor Necrosis Factor-alpha | 2003 |
Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.
Topics: Acetylcholine; Aged; Aged, 80 and over; Arginine; Atrial Appendage; Benzazepines; Electric Stimulation; Female; Heart Failure; Humans; Male; Middle Aged; Neuropeptide Y; Presynaptic Terminals; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; Vasodilator Agents | 2004 |
Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy.
Topics: Adolescent; Adult; Aged; Arginine; Blood Pressure; Cardiomyopathy, Dilated; Child; Female; Finland; Follow-Up Studies; Genetic Predisposition to Disease; Glutamine; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Mutation; Myosin Heavy Chains; Pedigree; Phenotype; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Sarcomeres; Stroke Volume; Tropomyosin; Troponin C; Troponin I; Troponin T; Tryptophan; Ventricular Myosins | 2004 |
Phenotype and genotype of Dent's disease in three Korean boys.
Topics: Arginine; Asian People; Child; Child, Preschool; Chloride Channels; Codon, Nonsense; Diuretics; Furosemide; Genotype; Glutamic Acid; Heart Failure; Humans; Infant; Kidney Calculi; Kidney Diseases; Kidney Tubules; Male; Phenotype; Serine; Ultrasonography | 2005 |
Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.
Topics: Adult; Aged; Arginine; Arteriosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis | 2005 |
Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts.
Topics: Amidohydrolases; Animals; Arginine; Blotting, Western; Cytochromes c; Dogs; Endothelium, Vascular; Heart Failure; Hemodynamics; Immunohistochemistry; Isoenzymes; Myocardium; Oxygen Consumption; Physical Exertion; Rest; Reverse Transcriptase Polymerase Chain Reaction; Subcellular Fractions; Vasodilation | 2005 |
Color blind, or just plain blind?
Topics: Arginine; Black People; Delayed-Action Preparations; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide; Pharmacogenetics; Vasodilator Agents | 2005 |
Chronic L-arginine supplementation enhances endurance exercise tolerance in heart failure patients.
Topics: Administration, Oral; Analysis of Variance; Arginine; Exercise Test; Exercise Tolerance; Heart Failure; Heart Rate; Humans; Lactates; Middle Aged; Oxygen Consumption; Time Factors; Treatment Outcome | 2006 |
Effects of losartan + L-arginine on nitric oxide production, endothelial cell function, and hemodynamic variables in patients with heart failure secondary to coronary heart disease.
Topics: Administration, Oral; Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Brachial Artery; Coronary Disease; Drug Therapy, Combination; Endothelium, Vascular; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Losartan; Male; Middle Aged; Nitric Oxide; Treatment Outcome; Ultrasonography, Doppler; Vasodilation | 2006 |
[Two cases of heparin-induced thrombocytopenia (HIT) and a review of the literature].
Topics: Aged; Antibodies; Arginine; Female; Heart Failure; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2006 |
High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure.
Topics: Aged; Arginine; Biomarkers; Cardiotonic Agents; Case-Control Studies; Comorbidity; Diabetes Complications; Digoxin; Diuretics; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Japan; Lysine; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Renal Insufficiency; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Survival Analysis | 2007 |
Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure.
Topics: Aged; Arginine; Austria; Biomarkers; Disease-Free Survival; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Prospective Studies; Risk Assessment; Ventricular Dysfunction, Left | 2007 |
Altered pulmonary microvascular reactivity to norepinephrine in canine pacing-induced heart failure.
Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Animals; Arginine; Cardiac Pacing, Artificial; Dogs; Heart Failure; Hemodynamics; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Pulmonary Circulation; Sympatholytics | 1994 |
Activity of the L-arginine/nitric oxide pathway and endothelin-1 in experimental heart failure.
Topics: Acetylcholine; Animals; Aorta; Arginine; Body Weight; Cricetinae; Disease Models, Animal; Endothelins; Endothelium, Vascular; Heart Failure; In Vitro Techniques; Male; Mesenteric Arteries; Mesocricetus; Muscle Relaxation; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Organ Size; Vascular Resistance | 1994 |
Effects of nitric oxide synthase inhibition on the muscle blood flow response to exercise in rats with heart failure.
Topics: Animals; Arginine; Blood Pressure; Female; Heart Failure; Heart Rate; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Physical Conditioning, Animal; Rats; Rats, Wistar; Regional Blood Flow; Vascular Resistance | 1995 |
Nitric oxide production and heart failure.
Topics: Arginine; Heart Failure; Humans; Nitrates; Nitric Oxide; omega-N-Methylarginine; Vascular Resistance; Vasoconstriction | 1995 |
Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?
Topics: Aged; Arginine; Cardiac Output, Low; Female; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Vasodilation | 1994 |
Enhanced basal nitric oxide production in heart failure.
Topics: Arginine; Heart Failure; Hemodynamics; Humans; Nitric Oxide; omega-N-Methylarginine | 1994 |
Lack of contribution of nitric oxide to basal vasomotor tone in heart failure.
Topics: Adult; Aged; Arginine; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Vascular Resistance | 1994 |
Enhanced basal nitric oxide production in heart failure.
Topics: Arginine; Heart Failure; Humans; Nitric Oxide; omega-N-Methylarginine; Vascular Resistance | 1994 |
Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure.
Topics: Acetylcholine; Arginine; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Hyperemia; Male; Middle Aged; Nitric Oxide; Nitroprusside; Plethysmography; Vascular Resistance; Vasodilation | 1994 |
Increased vascular responsiveness to norepinephrine in rats with heart failure is endothelium dependent. Dissociation of basal and stimulated nitric oxide release.
Topics: Animals; Aorta, Thoracic; Arginine; Cyclic GMP; Endothelium, Vascular; Heart Failure; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Vasoconstriction; Vasoconstrictor Agents | 1994 |
Increased production of nitric oxide in coronary arteries during congestive heart failure.
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Arginine; Atrial Natriuretic Factor; Azepines; Blood Pressure; Calcimycin; Cardiac Output; Coronary Vessels; Dinoprost; Dogs; Endothelium, Vascular; Femoral Artery; Heart Failure; Hemodynamics; In Vitro Techniques; Indomethacin; Isometric Contraction; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Pertussis Toxin; Reference Values; Renal Artery; Renin; Vascular Resistance; Virulence Factors, Bordetella | 1994 |
Physical training improves endothelial function in patients with chronic heart failure.
Topics: Adult; Arginine; Chronic Disease; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Physical Education and Training; Regional Blood Flow | 1996 |
Acute effect of L-arginine on hemodynamics and vascular capacitance in the canine pacing model of heart failure.
Topics: Animals; Arginine; Blood Pressure; Blood Volume; Cardiac Output; Cardiac Pacing, Artificial; Coronary Circulation; Disease Models, Animal; Dogs; Heart Arrest; Heart Failure; Nitric Oxide; Pulmonary Wedge Pressure; Vascular Capacitance; Vascular Resistance | 1995 |
Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg-->Cys mutation in the beta-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure.
Topics: Adolescent; Adult; Amino Acid Sequence; Arginine; Base Sequence; Cardiomyopathy, Hypertrophic; China; Chromosome Mapping; Chromosomes, Human, Pair 14; Cysteine; Death, Sudden; DNA Primers; Family; Female; Genetic Linkage; Heart Failure; Humans; Male; Molecular Sequence Data; Myosin Heavy Chains; Pedigree; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Prognosis; Survival Analysis | 1996 |
Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide.
Topics: Adult; Aged; Arginine; Blood Flow Velocity; Blood Pressure; Exercise Test; Female; Forearm; Hand Strength; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Vasodilation | 1996 |
Role of endothelium in control of forearm blood flow in patients with heart failure.
Topics: Acetylcholine; Adult; Aged; Arginine; Endothelium, Vascular; Forearm; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Substance P; Vascular Resistance; Vasodilator Agents; Vasomotor System | 1996 |
Altered vasodilator response of coronary microvasculature in pacing-induced congestive heart failure.
Topics: Acetylcholine; Animals; Arginine; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Heart Failure; Male; Microcirculation; Nitric Oxide; Nitroarginine; Nitroglycerin; Vasodilation | 1996 |
L-arginine increases exercise-induced vasodilation of the forearm in patients with heart failure.
Topics: Aged; Arginine; Exercise; Female; Forearm; Heart Failure; Hemodynamics; Humans; Male; Matched-Pair Analysis; Middle Aged; Oxygen Consumption; Regional Blood Flow; Vasodilation | 1997 |
Nitric oxide puzzles and paradoxes in heart failure: how to fit the pieces together?
Topics: Arginine; Biological Transport; Endothelium, Vascular; Erythrocytes; Heart Failure; Homeostasis; Humans; Nitric Oxide; Nitric Oxide Synthase | 1998 |
Increased L-arginine transport in human erythrocytes in chronic heart failure.
Topics: Amino Acids; Arginine; Biological Transport; Chromatography, High Pressure Liquid; Erythrocytes; Ethylmaleimide; Heart Failure; Humans; Nitric Oxide Synthase; omega-N-Methylarginine | 1998 |
Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Arginine; Endothelium, Vascular; Heart Failure; Kidney; Male; Metabolic Clearance Rate; Nitric Oxide Synthase; Nitroprusside; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Renal Circulation; Vasodilation; Vasodilator Agents | 1998 |
Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide.
Topics: Animals; Arginine; Carbon Dioxide; Cardiac Pacing, Artificial; Carotid Body; Chemoreceptor Cells; Disease Models, Animal; Heart Failure; Hypoxia; Male; Nitric Oxide Synthase; Nitroarginine; Oxygen; Partial Pressure; Rabbits | 1999 |
Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure.
Topics: Adult; Aged; Arginine; Cardiomyopathies; Creatinine; Exercise Test; Female; Heart Failure; Humans; Leg; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrogen Isotopes; Reference Values; Regional Blood Flow; Urea; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
Effects of L-arginine on endothelial and cardiac function in rats with heart failure.
Topics: Animals; Aorta, Thoracic; Arginine; Endothelium, Vascular; Heart; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Nitrates; Nitrites; Rats; Rats, Sprague-Dawley; Vasodilation | 1999 |
The effect of a neuropeptide Y antagonist, BIBP 3226, on short-term arterial pressure control in conscious unrestrained rats with congestive heart failure.
Topics: Animals; Arginine; Blood Pressure; Chronic Disease; Heart Failure; Heart Rate; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stroke Volume; Ventricular Function, Left | 1999 |
Impaired endothelium-mediated vasodilation is not the principal cause of vasoconstriction in heart failure.
Topics: Acetylcholine; Adult; Arginine; Endothelium, Vascular; Heart Failure; Hemodynamics; Humans; Middle Aged; Nitroprusside; Stress, Psychological; Vasoconstriction; Vasodilation; Vasodilator Agents | 2000 |
L-arginine reduces heart rate and improves hemodynamics in severe congestive heart failure.
Topics: Adult; Arginine; Endothelium, Vascular; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Middle Aged; Nitric Oxide; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Left | 2000 |
Inducible nitric oxide synthase-derived superoxide contributes to hypereactivity in small mesenteric arteries from a rat model of chronic heart failure.
Topics: Animals; Arginine; Coronary Disease; Dose-Response Relationship, Drug; Endothelium; Heart Failure; Immunohistochemistry; Male; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Potassium Chloride; Rats; Rats, Wistar; Superoxides; Vasodilation | 2000 |
Increased L-arginine uptake and inducible nitric oxide synthase activity in aortas of rats with heart failure.
Topics: Animals; Aorta; Arginine; Blood Pressure; Disease Models, Animal; DNA Primers; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heart Failure; Heart Rate; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Tritium; Tumor Necrosis Factor-alpha; Ventricular Pressure | 2001 |
Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction.
Topics: Amino Acid Transport Systems; Animals; Arginine; Argininosuccinate Synthase; Citrulline; Echocardiography; Female; Gene Expression; Gene Expression Regulation, Enzymologic; Heart Failure; Hemodynamics; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2002 |
Oral administration of L-arginine prevents congestive heart failure in murine viral myocarditis.
Topics: Administration, Oral; Animals; Arginine; Cardiovirus Infections; Chronic Disease; Encephalomyocarditis virus; Heart Failure; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Myocarditis | 2002 |
Endothelial function in chronic congestive heart failure.
Topics: Acetylcholine; Adult; Arginine; Blood Flow Velocity; Brachial Artery; Chronic Disease; Endothelium, Vascular; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Nitroglycerin; omega-N-Methylarginine; Radius; Regional Blood Flow; Ultrasonography; Vascular Resistance; Vasodilation; Vasomotor System | 1992 |
Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure.
Topics: Animals; Arginine; Cardiac Pacing, Artificial; Dogs; Endothelium, Vascular; Heart Failure; Hemodynamics; Nitric Oxide; Nitroarginine; Vasoconstriction | 1991 |
[Treatment of cardiac insufficiency with Rocamaline in association with cardiotonics].
Topics: Arginine; Digitalis Glycosides; Drug Synergism; Heart Failure; Humans; Malates | 1968 |
Cardiovascular toxic effects of VM26 in the treatment of acute lymphatic leukemia. Presentation of two cases.
Topics: Cardiovascular System; Child; Heart Failure; Humans; Hypertension; Leukemia, Lymphoid; Male; Podophyllotoxin; Teniposide | 1982 |